Symbotic (NASDAQ:SYM) Stock, Quote.Headers.trade-ideas

Symbotic

Symbotic Inc is an automation technology company that develops technologies to improve operating efficiencies in modern warehouses. The group develops, commercializes, and deploys innovative, end-to-end technology solutions that dramatically improve supply chain operations. Symbotic also automates the processing of pallets and cases in large warehouses or distribution centers for some of the retail and wholesale companies in the world. The company operates in two geographical regions the United States and Canada. Key revenue is generated from the United States.

Screenshot 2024-09-03 at 2.35.29 PM

Equities

News

Markets

General

SFTBY

The company&#39;s value has now decreased to under $10 billion.

SoftBank, Walmart-Backed Robotics Giant Sees $9B Wipeout In Founder&#39;s Wealth After Company Stock That Surged Nearly 325% Last Year Takes A Steep Decline

dollar general shutter

Large Cap

Movers

Trading Ideas

COIN

DLTR

MSTR

NBIX

OKTA

Citigourp Global Markets 2% Protected Notes Linked To The Djia

PSTG

SMCI

10 worst performing large-cap stocks in the last week. Dollar General, Super Micro Computer, Okta, Pure Storage, Neurocrine Biosciences among them.

Dollar General, Temu Parent PDD And Super Micro Computer Are Among Top 10 Large Cap Losers Last Week (Aug 25-Aug 31): Are The Others In Your Portfolio?

Dell Technologies

Long Ideas

Media

ACAD

DELL

LCID

SOFI

UWMC

Cramer gives his take on E.l.f Beauty, Acadia Pharmaceuticals, B&amp;G Foods, Lucid, SoFi, Dell, Johnson &amp; Johnson, UWM and Symbotic.

Jim Cramer Believes In Dell CEO, Doesn&#39;t Like B&amp;G Foods

Symbotic Inc

SYMBIO PHARMS LTD S/ADR by Symbio Pharmaceuticals Ltd

SymBio Pharmaceuticals Ltd

SYMPHONY INTERNATIONAL HOLDINGS ORD

Symbol

SYMBOLIC LOGIC INC by Symbolic Logic Inc.

Symbolic Logic Inc

SYMMETRY TECHNOLOGIES INC by Symmetry Technologies, Inc.

Symmetry Technologies Inc

SYMPHONY HOLDINGS ORD by Symphony Holdings, Ltd.

Symphony Holdings Ltd

SYMPHONY INTL HLDGS ORD by Symphony International Holdings Ltd.

Symphony International Holdings Ltd

Symrise AG

SHEL

Shell Announces Early Participation Results And Increases Maximum Old Notes Accepted In Exchange Offers To $12B, Extends Early Participation Premium To All Holders Until October 3, 2024

WIIM

APLD

ARBK

BITF

BTBT

BTDR

CIFR

CLSK

FUFU

HIVE

IREN

MARA

RIOT

WULF

Shares of crypto-linked stocks are trading higher after the Fed's Wednesday decision to cut rates by 50 basis points.

On CNBC's &#8220;Mad Money Lightning Round,&#8221; Jim Cramer said Wells Fargo &amp; Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WFC#NYSE">WFC</a>) is going to go higher, adding that <a href="https://www.benzinga.com/quote/WFC">it's a &#8220;winner.&#8221;</a>
On Sept. 17, the San Francisco-based bank launched specialized Application Programming Interfaces (APIs) for its Commercial Banking clients, expanding its API portfolio. 
These APIs offer real-time data access aimed at boosting sales, improving liquidity, reducing credit risk, and cutting expenses for floorplan and channel finance clients <a href="https://www.benzinga.com/markets/equities/24/09/40903846/wells-fargo-launches-new-apis-to-boost-efficiency-and-productivity-details">across several industries.</a>
&#8220;It's had too big a move up,&#8221; Cramer said when asked about Iron Mountain Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IRM#NYSE">IRM</a>). &#8220;Let's move on.&#8221;
On Aug. 1, Iron Mountain reported better-than-expected second-quarter financial results and issued FY24 AFFO guidance above estimates. Also, the company increased its quarterly dividend.
Palantir Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NYSE">PLTR</a>) is a &#8220;cold&#8221; stock, Cramer said.
On Sept. 17, the company inked a multi-year, multi-million-dollar contract with Nebraska Medicine. As per the deal, Palantir will utilize its Artificial Intelligence Platform (AIP) to enhance healthcare through <a href="https://www.benzinga.com/markets/equities/24/09/40898997/palantirs-ai-powers-nebraska-medicine-inks-multi-million-dollar-deal-to-advance-patient-care">transformative technologies</a>.
The &#8220;Mad Money&#8221; host recommended buying PG&amp;E Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PCG#NYSE">PCG</a>). &#8220;That stock is a good one, rate increase or no,&#8221; he added.
On Sept. 12, B of A Securities analyst Ross Fowler reinstated PG&amp;E with a Buy and announced a $24 price target.
Price Action:
<ul>
<li>Iron Mountain shares gained 0.5% to settle at $116.45 on Wednesday.</li>
<li>Wells Fargo shares fell 0.5% to close at $54.26 during the session.</li>
<li>Palantir shares fell 0.2% to close at $36.38 during Wednesday's session.</li>
<li>PG&amp;E shares fell 1.8% to settle at $19.51.</li>
</ul>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/24/09/40927530/coinbase-global-electronic-arts-and-2-other-stocks-executives-are-selling">Coinbase Global, Electronic Arts And 2 Other Stocks Executives Are Selling</a></li>
</ul>
Image: Wikimedia Commons

PLTR

Jim Cramer: This Utilities Stock Is A Buy, Calls Wells Fargo A 'Winner'

GOLD

RGLD

SAND

SSRM

Shares of precious metals stocks are trading higher as gold and silver rise after the Fed on Wednesday cut rates by 50 basis points.

Neuronetics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STIM#NASDAQ">STIM</a>), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced that additional payors have updated their TMS (transcranial magnetic stimulation) coverage to reduce access barriers for patients with major depressive disorder (MDD). This expanded access allows people to receive treatment such as the Company's NeuroStar TMS Therapy earlier in their treatment regimen. &nbsp;
Effective immediately, BlueCross BlueShield (BCBS) of North Carolina has expanded its TMS policy to cover adolescents 15 years and older, based on <a href="https://www.globenewswire.com/Tracker?data=qOjmrE7PDpP0iP9SeWY9op5d18oOTSBdwoHIgNjWAn9BzTHKJw9PTdysQO-eW_OwlcEPZmltrdKKK9KXWOYbH0guJe1aSPys58MhR2z9MpsyUuVQf30nDJt9tcdg63BOk1ofdy5n2Zww3OInMUpL_Y8tJjvwaSiZUMT9EOfhJsrKFd1MjahDQJshs_0Kj9s0Pqw_JG1TwBnpdISbSaL68ADhCfPeFL9ulYxPYeNG2OU=">recent clearance</a> from the United States Food and Drug Administration (FDA) for NeuroStar as the first and only TMS treatment authorized for this population. BCBC of North Carolina policies affect more than 2.2 million covered lives. Additionally, Louisiana Medicaid has started covering TMS for adults 18 and older, effective immediately. This is the first TMS coverage policy from Louisiana Medicaid, which has a footprint of more than 1.6 million covered lives.
 &nbsp;

Biotech

STIM

Neuronetics Announces That Additional Payors Have Updated Their TMS Coverage To Reduce Access Barriers For Patients With Major Depressive Disorder

<a href="https://www.globenewswire.com/Tracker?data=9txYGzddj5XqmkcafzxA8gN1tMoQQDSUNEVs8NM94vL9xd-NLcHOgSNon4qsstt91oexNNWCY_yUOlGuL7rPTA==">RenovoRx, Inc</a>. ("RenovoRx" or the "Company") (NASDAQ:<a href="https://www.benzinga.com/stock/RNXT#NASDAQ">RNXT</a>), a clinical-stage biopharmaceutical company developing novel precision oncology therapies based on a local drug-delivery platform, today announced that Ripal Gandhi, M.D., FSIR, FSVM will present at the Symposium on Clinical Interventional Oncology ("CIO") which is being held September 20-22, 2024, at the Loews Hotel in Miami Beach, Florida. Dr. Gandhi's presentation will highlight RenovoRx's TAMP (Trans-Arterial Micro-Perfusion) therapy platform for the treatment of locally advanced pancreatic cancer ("LAPC") and recent publications of clinical data.
Dr. Gandhi, professor of Interventional Radiology at the Miami Cancer Institute and Miami Cardiac and Vascular Institute, Florida International University Herbert Wertheim College of Medicine, is a Course Director for the Symposium on CIO. Since 2018, Dr. Gandhi has been instrumental as a principal investigator for the Miami Cancer Institute in RenovoRx's pivotal ongoing Phase III TIGeR-PaC clinical trial in LAPC.
Dr. Gandhi's presentation will&nbsp;provide an overview of the clinical challenges of the standard of care treatment available to LAPC patients. Systemic (intravenous) chemotherapy, while considered the standard-of-care for LAPC, is often associated with debilitating side effects, and may have limited effectiveness in treating this type of cancer due to tumors lacking dedicated blood vessels critical for delivering chemotherapy. Dr. Gandhi will highlight the TAMP therapy platform and the opportunity it may give to LAPC patients as a potential targeted oncology option for treatment.
Dr. Gandhi will also discuss the status of the Company's ongoing Phase III TIGeR-PaC study, which is evaluating the use of the TAMP therapy platform with gemcitabine HCl in patients with LAPC. Additionally, he will review a recent publication in the international peer-reviewed journal, The Oncologist&#xAE;, of early-stage clinical data on the intra-arterial administration of gemcitabine HCl utilizing the TAMP including Phase I/II dose escalation safety study (RR1) and acquired data from a post-marketing post-treatment observational registry study (RR2).

RNXT

RenovoRx Announces Presentation At Symposium On Clinical Interventional Oncology Highlighting TAMP For Targeted Treatment Of Locally Advanced Pancreatic Cancer On Saturday, September 21, 2024

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
<ul>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5e60ff475f2b9b000113c537/adam-maeder">Piper Sandler analyst Adam Maeder</a> initiated coverage on Abbott Laboratories (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABT#NYSE">ABT</a>) with an Overweight rating and announced a price target of $131. Abbott shares fell 2.8% to close at $114.88 on Wednesday. <a href="https://www.benzinga.com/quote/ABT/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Roth MKM analyst Scott Fortune initiated coverage on Turning Point Brands, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPB#NYSE">TPB</a>) with a Buy rating and announced a price target of $50. Turning Point Brands shares gained 0.9% to close at $39.03 on Wednesday. <a href="https://www.benzinga.com/quote/TPB/analyst-ratings">See how other analysts view this stock.</a></li>
<li>R<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/641c1355c9c7840001d30a8f/james-rollyson">aymond James analyst James Rollyson</a> initiated coverage on Helix Energy Solutions Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HLX#NYSE">HLX</a>) with a Strong Buy rating and announced a price target of $14. Helix Energy shares fell 1.8% to close at $9.84 on Wednesday. <a href="https://www.benzinga.com/quote/HLX/analyst-ratings">See how other analysts view this stock.</a></li>
<li>RBC Capital analyst Jonathan Atkin initiated coverage on Charter Communications, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHTR#NASDAQ">CHTR</a>) with a Sector Perform rating and announced a price target of $345. Charter Communications shares gained 0.1% to close at $339.64 on Wednesday. <a href="https://www.benzinga.com/quote/CHTR/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Mizuho analyst William Janela initiated coverage on Northern Oil and Gas, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOG#NYSE">NOG</a>) with an Outperform rating and announced a price target of $47. Northern Oil &amp; Gas shares rose 0.3% to close at $36.17 on Wednesday. <a href="https://www.benzinga.com/quote/NOG/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying ABT stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="512" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19083945/image-154-1024x512.png" alt="" class="wp-image-556133" style="width:656px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19083945/image-154-1024x512.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19083945/image-154-300x150.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19083945/image-154-768x384.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19083945/image-154.png 1325w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/09/40925678/fedex-gears-up-for-q1-print-here-are-the-recent-forecast-changes-from-wall-streets-most-accurate-an">FedEx Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street&#8217;s Most Accurate Analysts</a></li>
</ul>

Initiation

Pre-Market Outlook

Analyst Ratings

CHTR

This Abbott Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

RZLV

Watching Rezolve AI; Shares Spike Higher As Co Issues PR Applauding The Recent Announcement By Microsoft And BlackRock To Invest $30B Into AI Infrastructure

Offerings

CRMT

America's Car-Mart Prices Public Offering Of 1.7M Shares At $43 Per Share, With Option For Additional 255K Shares; Proceeds To Repay Credit Facilities And Fund Corporate Purposes

Intelligent Bio Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INBS#NASDAQ">INBS</a>) reported $730.00 thousand in sales this quarter. This is a 64.74 percent increase over sales of $443.13 thousand the same period last year.

Earnings

Intelligent Bio Solutions Inc. - Common Stock

INBS

Intelligent Bio Solutions Q4 Sales $730.00K Up From $443.13K YoY

HOOD

Robinhood Markets shares are trading higher after Piper Sandler maintained an Overweight rating on the stock and raised its price target from $23 to $27.

SNOA

Sonoma Pharmaceuticals Receives FDA 510(k) Clearance For Microcyn Solution With Expanded Over-The-Counter Indications For Face, Eyelid, And Eyelashes

As of Sept. 19, 2024, three stocks in the consumer staples sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the <a href="https://www.benzinga.com/topic/rsi">RSI is above 70</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>. 
Here's the latest list of major overbought players in this sector.
<h3 class="wp-block-heading">Instacart (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CART#NASDAQ">CART</a>)</h3>
<ul>
<li>On Sept. 5, Cantor Fitzgerald analyst Deepak Mathivanan initiated coverage on CART with an Overweight rating and announced a price target of $45.. The company's stock gained around 19% over the past month and has a <a href="https://www.benzinga.com/quote/CART">52-week high of $42.95</a>.</li>
<li>RSI Value: 76.17&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>CART Price Action: Shares of Instacart gained 5.3% to close at $39.87 on Wednesday.</li>
</ul>
<h3 class="wp-block-heading">US Foods Holding Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USFD#NYSE">USFD</a>)</h3>
<ul>
<li>On Sept. 18, Wells Fargo analyst Edward Kelly maintained US Foods with an Overweight and raised the price target from $66 to $75. The company's stock gained around 5% over the past five days and <a href="https://www.benzinga.com/quote/USFD">has a 52-week high</a> of $62.34.</li>
<li>RSI Value: 73.11</li>
<li>USFD Price Action: Shares of US Foods fell 0.4% to close at $60.91 on Wednesday.</li>
</ul>
<h3 class="wp-block-heading">Monster Beverage Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNST#NASDAQ">MNST</a>)</h3>
<ul>
<li>On Aug. 19, Monster Beverage said its board authorized a new share repurchase program of up to $500 million of the company's outstanding common stock. As of Aug. 19, there were no authorized share repurchases remaining under the company's previously authorized buyback program. The company's stock gained around 12% over the past month and has a <a href="https://www.benzinga.com/quote/MNST">52-week high</a> of $61.22.</li>
<li>RSI Value: 71.75</li>
<li>MNST Price Action: Shares of Monster Beverage rose 2.5% to close at $52.35 on Wednesday. </li>
</ul>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/09/40925678/fedex-gears-up-for-q1-print-here-are-the-recent-forecast-changes-from-wall-streets-most-accurate-an">FedEx Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street&#8217;s Most Accurate Analysts</a></li>
</ul>

Short Ideas

CART

MNST

USFD

Top 3 Defensive Stocks You May Want To Dump In September

Lennar Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEN#NYSE">LEN</a>) will release earnings results for its third quarter, after the closing<a href="https://www.benzinga.com/quote/LEN/earnings"> bell on Thursday, Sept. 19.</a>
Analysts expect the Miami, Florida-based company to report quarterly earnings at $3.63 per share, down from $3.87 per share in the year-ago period. Lennar projects to report revenue of $9.16 billion for the quarter, compared to $8.45 billion a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On June 17, Lennar reported quarterly earnings of $3.38 per share, which beat the analyst consensus estimate of $3.24 per share.
Lennar shares fell 0.5% to close at $188.43 on Wednesday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/TJX/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5967569b988ca8000127b8db/jay-mccanless">Wedbush analyst Jay McCanless</a> reiterated a Neutral rating with a price target of $144 on Sept. 11. This analyst has an accuracy rate of 84%.</li>
<li>Wells Fargo analyst Sam Reid maintained an Overweight rating and raised the price target from $195 to $205 on Sept. 9. This analyst has an accuracy rate of 85%.</li>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/584feeb6ee7bf600019078df/jade-rahmani">Keefe, Bruyette &amp; Woods analyst Jade Rahmani </a>maintained an Outperform rating and boosted the price target from $183 to $230 on Sept. 4. This analyst has an accuracy rate of 77%.</li>
<li>Seaport Global analyst Kenneth Zener downgraded the stock from Buy to Neutral on Aug. 5. This analyst has an accuracy rate of 75%.</li>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5901e8e90bd9910001e193f6/stephen-kim">Evercore ISI Group analyst Stephen Kim</a> maintained an Outperform rating and raised the price target from $237 to $240 on July 15. This analyst has an accuracy rate of 79%.</li>
</ul>
Considering buying LEN stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="520" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19023214/image-143-1024x520.png" alt="" class="wp-image-555416" style="width:632px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19023214/image-143-1024x520.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19023214/image-143-300x152.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19023214/image-143-768x390.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19023214/image-143.png 1322w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/24/09/40927530/coinbase-global-electronic-arts-and-2-other-stocks-executives-are-selling">Coinbase Global, Electronic Arts And 2 Other Stocks Executives Are Selling</a></li>
</ul>

Price Target

Lennar Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Oracle Corp's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>) CloudWorld in Las Vegas had no shortage of artificial intelligence (AI) buzz, but investors hoping for a quick windfall might need <a href="https://www.benzinga.com/quote/ORCL/news">to temper expectations</a>.
JPMorgan analyst Tien-tsin Huang, who attended the event, noted that while Oracle's multi-cloud advancements are laying the groundwork for the future, the immediate impact on revenues is still uncertain.
"We saw numerous examples of high-value AI-driven tech services," Huang stated, highlighting the long-term potential of AI in transforming enterprise workflows. 
However, he remains cautious about the near-term outlook, adding, "Near-term demand improvement remains elusive," despite growing client interest in AI.
<h2 class="wp-block-heading">Oracle Makes A Big Move</h2>
Oracle's big move at CloudWorld was its announcement of Oracle Database (ODB) on AWS, building on similar launches with Microsoft Corp&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) Azure and Alphabet Inc&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) Google Cloud.
This multi-cloud push, Huang believes, is a critical strategy for companies looking to "maximize the value of GenAI" by optimizing data across different platforms.
Read Also: <a href="https://www.benzinga.com/startups/24/09/40922366/oracles-larry-ellison-briefly-became-wealthier-than-jeff-bezos-heres-how-his-fortune-outpaced-amazon">Oracle&#8217;s Larry Ellison Briefly Became Wealthier Than Jeff Bezos. Here&#8217;s How His Fortune Outpaced Amazon&#8217;s Founder</a>
<h2 class="wp-block-heading">Yet To See Material Revenue Momentum</h2>
Yet, the short-term demand for tech services in AI remains lukewarm. "We did not sense that any have achieved material revenue momentum in the category," Huang observed, signaling that while enterprise clients are interested in AI, the financial payoff might still be a few quarters away.
<h2 class="wp-block-heading">Accenture: A Secular Winner</h2>
Long-term, Huang is optimistic about Oracle and its tech services partners, particularly Accenture PLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACN#NYSE">ACN</a>), which he sees "as a secular winner" in helping companies customize and optimize generative AI solutions for business processes.
As companies transition to a more interoperable, multi-cloud environment, the opportunities for AI and tech services will grow, but patience is key.
For now, investors should keep their eyes on the big picture, as the immediate AI windfall for Oracle might take some time to materialize.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/m-a/24/09/40926078/nvidia-considers-165m-octoai-acquisition-aims-to-strengthen-ai-and-cloud-dominance">Nvidia Considers $165M OctoAI Acquisition, Aims to Strengthen AI and Cloud Dominance</a></li>
</ul>
Image: Shutterstock

GOOG

GOOGL

MSFT

ORCL

Oracle CloudWorld Highlights 'AI-Driven Tech Services,' But Revenue Growth Requires Patience: Analyst

The Nasdaq 100 closed lower by around 0.5% during Wednesday's session. Investors, meanwhile, focused on some notable insider trades.
When insiders sell shares, it could be a preplanned sale, or could indicate their concern in the company's prospects or that they view the stock as being overpriced. Insider sales should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a selling decision.
Below is a look at a few recent notable insider sales. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/">Benzinga&#8217;s insider transactions</a> platform.
<h3 class="wp-block-heading">Alphabet</h3>
<ul>
<li>The Trade: Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) CEO Sundar Pichai <a href="https://www.benzinga.com/sec/insider-trades/">sold a total of 22,500 shares</a> at an average price of $160.63. The insider received around $3.61 million from selling those shares.</li>
<li>What's Happening: Alphabet's Google won its appeal against the European Commission&#8217;s €1.49 billion ($1.66 billion) antitrust fine for anticompetitive practices involving its online search advertising business.</li>
<li>What Alphabet Does: Alphabet is a holding company that wholly owns internet giant Google.</li>
<li>Benzinga Pro's real-time newsfeed alerted to<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent091924&amp;t=be2bearmibe3na1"> latest GOOG new</a>s. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent091924&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="910" height="830" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19044828/image-145.png" alt="" class="wp-image-555611" style="width:716px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19044828/image-145.png 910w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19044828/image-145-300x274.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19044828/image-145-768x700.png 768w" sizes="(max-width: 910px) 100vw, 910px" /></a></figure>
<h3 class="wp-block-heading">Williams-Sonoma</h3>
<ul>
<li>The Trade: Williams-Sonoma, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WSM#NYSE">WSM</a>) President and CEO Laura Alber <a href="https://www.benzinga.com/sec/insider-trades/">sold a total of 40,000 shares</a> at an average price of $145.27. The insider received around $5.8 million from selling those shares.</li>
<li>What's Happening: On Sept. 16, TD Cowen analyst Max Rakhlenko maintained Williams-Sonoma with a Buy and raised the price target from $150 to $160.</li>
<li>What Williams-Sonoma Does: With a retail and direct-to-consumer presence, Williams-Sonoma is a player in the $300 billion domestic home category and $450 billion international home market, focused on expanding its exposure in the B2B ($80 billion total addressable market), marketplace, and franchise areas. </li>
<li>Benzinga Pro&#8217;s charting tool helped identify the<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent091924&amp;t=be2bearmibe3na1"> trend in WSM stock</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent091924&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="927" height="837" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19044933/image-146.png" alt="" class="wp-image-555616" style="width:705px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19044933/image-146.png 927w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19044933/image-146-300x271.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19044933/image-146-768x693.png 768w" sizes="(max-width: 927px) 100vw, 927px" /></a></figure>
<h3 class="wp-block-heading">Ross Stores</h3>
<ul>
<li>The Trade: Ross Stores, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROST#NASDAQ">ROST</a>) Group President, COO Michael J. Hartshorn <a href="https://www.benzinga.com/sec/insider-trades/">sold a total of 8,366 shares</a> at an average price of $155.64. The insider received around $1.3 million from selling those shares.</li>
<li>What's Happening: On Aug. 22, Ross Stores reported better-than-expected second-quarter financial results and raised its FY24 EPS guidance with its midpoint above estimates.</li>
<li>What Ross Stores Does: Ross Stores operates as an off-price apparel and accessories retailer with the majority of its sales derived from its Ross Dress for Less banner. </li>
<li>Benzinga Pro&#8217;s signals feature notified of a potential <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent091924&amp;t=be2bearmibe3na1">breakout in ROST</a> shares. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent091924&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="875" height="841" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19045018/image-147.png" alt="" class="wp-image-555619" style="width:630px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19045018/image-147.png 875w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19045018/image-147-300x288.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19045018/image-147-768x738.png 768w" sizes="(max-width: 875px) 100vw, 875px" /></a></figure>
<h3 class="wp-block-heading">McDonald&#8217;s</h3>
<ul>
<li>The Trade: McDonald&#8217;s Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCD#NYSE">MCD</a>) Chairman and CEO Christopher J Kempczinski <a href="https://www.benzinga.com/sec/insider-trades/">sold a total of 3,934 shares</a> at an average price of $300.00. The insider received around $1.2 million from selling those shares.</li>
<li>What's Happening: On Sept. 16, JP Morgan analyst John Ivankoe maintained McDonald&#8217;s with an Overweight and raised the price target from $270 to $290.</li>
<li></li>
<li>What McDonald&#8217;s Does: McDonald&#8217;s is the largest restaurant owner-operator in the world, with 2023 system sales of $130 billion across nearly than 42,000 stores and 115 markets. </li>
<li>Benzinga Pro's earnings calendar was used to track upcoming <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent091924&amp;t=be2bearmibe3na1">MCD&#8217;s earnings repor</a>ts. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent091924&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="860" height="813" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19045124/image-148.png" alt="" class="wp-image-555620" style="width:601px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19045124/image-148.png 860w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19045124/image-148-300x284.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19045124/image-148-768x726.png 768w" sizes="(max-width: 860px) 100vw, 860px" /></a></figure>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/09/40925678/fedex-gears-up-for-q1-print-here-are-the-recent-forecast-changes-from-wall-streets-most-accurate-an">FedEx Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street&#8217;s Most Accurate Analysts</a></li>
</ul>

Insider Trades

ROST

Alphabet, McDonald's And 2 Other Stocks Executives Are Selling

COUR

Coursera shares are trading higher are trading higher after B of A Securities initiated coverage on the stock with a Buy rating and announced an $11 price target.

Ahead of the 2024 election, Kamala Harris and Oprah Winfrey are set to host a virtual event aimed at rallying support in key battleground states.
What Happened: Harris and Winfrey will join forces for an online event on Thursday aimed at rallying support in key battleground states, according to Reuters on Thursday.
The &#8220;Unite for America&#8221; event, co-hosted by Winfrey and the activist group &#8220;Win with Black Women,&#8221; seeks to register voters and bolster Harris&#8217;s campaign in states like Pennsylvania, Georgia, and Michigan. The event will be live-streamed at 8 p.m. EDT (0000 GMT) on social media platforms including Instagram and TikTok.
On the same day, Donald Trump will attend a Washington event on fighting antisemitism and address the Israeli-American Council Summit.
Harris has been campaigning in Michigan, specifically in the Detroit area, local press reported. Numerous grassroots organizations, such as &#8220;Latinas for Harris,&#8221; &#8220;Win With Black Men,&#8221; and &#8220;Republicans for Harris,&#8221; are participating in the event. Win with Black Women focuses on helping Black women win elected offices.
Since Harris entered the race in July, these groups have raised over $20 million for her campaign, according to a press release from Unite for America. Winfrey emphasized the importance of voter motivation and planning in a statement.
See Also: <a href="https://www.benzinga.com/general/politics/24/09/40910999/trump-in-trouble-vice-president-harris-has-record-6-point-lead-in-2024-election-poll-after-debat?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Trump In Trouble: Vice President Harris Has Record 6-Point Lead In 2024 Election Poll After Debate, Posts Highest Rankings In Key Demographics</a>
According to a recent Reuters poll, Harris leads her Republican opponent Donald Trump 47% to 42%. Harris is ahead in battleground states like Michigan, Pennsylvania, and Wisconsin, while Trump has more support in Georgia.
Why It Matters: Harris&#8217;s campaign has seen significant momentum recently. A recent survey of fund managers, strategists, and economists revealed that <a href="https://www.benzinga.com/news/24/09/40913930/kamala-harris-moves-from-13-point-deficit-to-7-point-lead-over-trump-in-survey-of-fund-managers-stra">Harris had moved from a 13-point deficit</a> to a 7-point lead over Trump. The survey, conducted by CNBC, showed Harris as the likely winner of the November election, with 48% support compared to Trump&#8217;s 41%. This shift in support came after Harris replaced President Joe Biden on the Democratic ticket in July.
Additionally, Harris received a rare endorsement from the <a href="https://www.benzinga.com/general/politics/24/09/40907893/kamala-harris-wins-second-endorsement-in-179-years-from-magazine-that-featured-works-from-nikola">oldest continuously published magazine </a>in the U.S., which has featured works from notable figures like Nikola Tesla and Albert Einstein. This endorsement is significant given the tight contest between Harris and Trump. 
Moreover, pop star Taylor Swift&#8217;s <a href="https://www.benzinga.com/general/entertainment/24/09/40824581/taylor-swifts-endorsement-of-kamala-harris-drives-over-330k-visitors-to-vote-gov">endorsement of Harris</a> drove over 330,000 visitors to vote.gov, highlighting the impact of celebrity endorsements on voter engagement. This surge occurred less than 24 hours after Swift&#8217;s endorsement following the debate between Harris and Trump.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/24/09/40911991/hillary-clinton-compares-melania-trump-to-the-little-kid-at-a-birthday-party-who-doesnt-know-anyone?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Hillary Clinton Compares Melania Trump To &#8216;The Little Kid At A Birthday Party Who Doesn&#8217;t Know Anyone&#8217; In Her Latest Book</a></li>
</ul>
Image via Shutterstock
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/topic/Pooja-Rajkumari" target="_blank" rel="noreferrer noopener">Pooja Rajkumari</a>

Politics

Kamala Harris And Oprah Winfrey To Host Virtual Event To Sway Support From Key Battleground States Of Pennsylvania, Georgia And Michigan As Trump Attends Washington Event

Neuraspace's Space Traffic Management (STM) platform provides cutting edge Artificial Intelligence (AI) and Machine Learning (ML) features that reinforce mission safety, efficiency and longevity for Sidus Space.
Sidus Space (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIDU#NASDAQ">SIDU</a>) (the "Company" or "Sidus"), a provider of end-to-end precision Space Infrastructure solutions and Data-as-a-Service products, announced today, at the <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwsbw.com%2F&amp;esheet=54124388&amp;newsitemid=20240919680196&amp;lan=en-US&amp;anchor=World+Space+Business+Week&amp;index=1&amp;md5=537ec7d1903b5bc087101aa73f3d3d2d">World Space Business Week</a> (WSBW) conference in Paris, the signing of an agreement with Neuraspace. Under the agreement, Neuraspace will provide Space Traffic Management and LEOP (Launch and Early Operations) support services to Sidus Space, thereby enhancing the Company's constellation operation capabilities.

SIDU

Sidus Space Enhances LizzieSat Constellation Operations Via Agreement With Neuraspace

At today's event, Thermo Fisher Scientific highlighted:
<ul>
<li>Incredibly well-positioned industry leadership, with leading businesses that enable our customers' success
<ul>
<li>Our industry-leading businesses are benefited by total company scale and capabilities. &nbsp;</li>
</ul>
</li>
<li>Attractive end markets that are fueled by enduring long-term trends
<ul>
<li>Thermo Fisher is the industry leader serving an attractive $235 billion market with long-term market growth of 4% to 6%. &nbsp;</li>
</ul>
</li>
<li>Proven growth strategy drives share gain
<ul>
<li>High-impact innovation: enabling major scientific breakthroughs.</li>
<li>The trusted partner to our customers: enabling customer success with an excellent reputation and credibility built over a long period of time.</li>
<li>Unparalleled commercial engine: commercial advantage through deep engagement with customers wherever they are. &nbsp;</li>
</ul>
</li>
<li>Practical Process Improvement Business System (PPI) enables outstanding execution
<ul>
<li>PPI is the core of Thermo Fisher's culture, with a focus on continuous improvement that drives quality, productivity and customer allegiance and engages every colleague to find a better way, every day.</li>
<li>PPI delivers competitive advantage and drives differentiated financial performance. &nbsp;</li>
</ul>
</li>
<li>Delivering differentiated value creation for all our stakeholders
<ul>
<li>Industry leading businesses have a long-standing track record of value creation.</li>
<li>Disciplined approach to capital deployment, which consists of strategic M&amp;A and returning capital to shareholders, enables us to better serve our customers and create tremendous value for our shareholders.</li>
<li>Mission-led comprehensive CSR strategy delivers competitive advantage through our innovations for a cleaner planet, investments in colleagues and communities and our focus on impact and accountability. More details can be found in the most recent <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fcorporate.thermofisher.com%2Fcontent%2Fdam%2Ftfcorpsite%2Fdocuments%2Fcorporate-social-responsibility%2Fannual-reports%2F2023-CSR-Report.pdf&amp;esheet=54124207&amp;newsitemid=20240919299545&amp;lan=en-US&amp;anchor=CSR+Report&amp;index=1&amp;md5=043c86c39168bf774d5a27615ad0617f">CSR Report</a>. &nbsp;</li>
</ul>
</li>
<li>Outstanding track record of financial performance and an excellent long-term outlook
<ul>
<li>Thermo Fisher's proven growth strategy drives share gain, and its capital deployment approach creates tremendous value, positioning the company to deliver organic revenue growth of 7% to 9% and mid-teens adjusted EPS growth over the long term.</li>
</ul>
</li>
</ul>

Thermo Fisher Scientific Hosts 2024 Investor Day, Showcasing Industry-Leading Businesses, Proven Growth Strategy, And Strong Long-Term Financial Outlook

Symbotic acquires Veo Robotics in $8.7M transaction

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
In a new InvestorPlace presentation, &ldquo;The Next Wave of Breakout Stocks,&rdquo; host Chris Hurt admits he has been one of the unlucky ones. He admits to missing out on, among plenty of others, these breakout stocks:



<ul><li>Energy drink maker Celsius (NASDAQ:<a href="https://investorplace.com/stock-quotes/celh-stock-quote/">CELH</a>), which is up 1,400%</li>



<li>AI GPU superstar Nvidia (NASDAQ:<a href="https://investorplace.com/stock-quotes/nvda-stock-quote/">NVDA</a>), up 1,000%</li>



<li>And robotics firm Symbotic (NASDAQ:<a href="https://investorplace.com/stock-quotes/sym-stock-quote/">SYM</a>), which has leaped 400%</li>
</ul>You might have missed out on these gains, too.



However, there&rsquo;s a good reason why picking these sorts of winners is so hard: They can look downright ugly before their breakouts.



In 2019, Celsius was a money-losing regional drink maker with no nationwide distribution network. Nvidia had just lost 50% of its value from the cryptocurrency hangover that same period. And in 2022, Symbotic looked more like a busted SPAC than the next AI superstar.



It&rsquo;s no wonder why Chris and thousands of others wanted to stay far, far away.



We&rsquo;re seeing the same story play out today. Last week, shares of some of the largest AI-focused firms tumbled as investors reconsidered their high-priced bets. Companies like chipmaker Intel (<a href="https://investorplace.com/stock-quotes/intc-stock-quote/">INTC</a>) have lost almost 50% in a month, which is why some people are comparing last week&rsquo;s volatility to 1987&rsquo;s &ldquo;Black Monday.&rdquo;



Things are ugly. And it&rsquo;s not clear which stocks to buy the dip on.



Fortunately, there&rsquo;s a solution. One that&rsquo;s taken years to develop. In his latest talk with InvestorPlace Chief Investment Analyst Luke Lango, Chris reveals how Luke and his team have created a quantitative-driven system that&rsquo;s able to cut through the &ldquo;ugliness&rdquo; and help them identify these diamonds-in-the-rough before they bounce back. It&rsquo;s called Prometheus, <a href="https://secure.investorplace.com/?cid=MKT803528&amp;eid=MKT811953&amp;step=start&amp;plcid=PLC213427">and you can learn more about it in their presentation here</a>.



Even better, many of the system&rsquo;s top picks are also the same ones our InvestorPlace.com writers have been eyeing. Together, we&rsquo;ve found a handful of companies that human and &ldquo;machine&rdquo; believe are set to rebound and potentially turn into breakout stocks.



<h2>Nvidia (NVDA)</h2>



Perhaps the greatest source of hand-wringing last week came from Nvidia, a company that many believed had grown too large, too quickly. It only took the chipmaker three months to move from a $2 trillion firm to a $3 trillion one earlier this year, which made the selloff equally violent. Last week&rsquo;s decline has now brought shares down 25% since their July peak &ndash; erasing almost that same trillion dollars from Nvidia&rsquo;s market value.



However, both Louis Navellier and Prometheus see an opportunity to buy the dip. As Louis bluntly puts it, <a href="https://investorplace.com/market360/2024/08/dont-let-talk-of-bubble-trouble-scare-you-off-nvidia-stock/'">don&rsquo;t let talk of &ldquo;bubble trouble&rdquo; scare you from Nvidia</a>:




It may be overstating it to say that NVDA is in &ldquo;bubble land.&rdquo; The GenAI boom took shape in early 2023. Since then, shares have surged by more than sevenfold.



However, earnings have gone up nearly tenfold during this time frame. In FY2023, Nvidia&rsquo;s earnings came at 18 cents per share. Over the trailing 12-month period, reported earnings have totaled $1.73 per share.




In other words, Nvidia&rsquo;s meteoritic rise has come with an even greater increase in profits. Shares of the company trade at just 25 times estimated 2025 earnings&hellip; hardly the stuff of bubbles. Earnings forecasts have also continued to increase, with the average analyst adding 3% to their earnings per share (<a href="https://investorplace.com/stock-quotes/eps-stock-quote/">EPS</a>) estimates over the past 30 days. This is historically a bullish sign of more gains to come.



Of course, there are some risks that Nvidia will fail to deliver on future earnings. Competition is rising among AI chip producers, just as data center players are facing mounting pressure to cut costs. But that&rsquo;s precisely why the stock has fallen 25% in the first place. Prometheus awards Nvidia a &gt;90 score, which suggests a rebound is likely over the next four weeks.



<h2>KLA (KLAC)</h2>



Shares of high-quality KLA (NASDAQ:<a href="https://investorplace.com/stock-quotes/klac-stock-quote/">KLAC</a>) have plunged 20% since July on similar concerns over AI chip demand. Investors are worried about data centers cutting semiconductor demand and have sold KLA along with lower-quality firms.



The Silicon Valley firm is one of the largest global manufacturers of wafer fabrication equipment for semiconductors, specializing in process control. It&rsquo;s an essential service that helps manufacturers inspect chips during research and production.



The complexity of KLA&rsquo;s equipment and relevant services means the company has incredible pricing power and scale. It&rsquo;s roughly four times larger than its closest competitor, according to analysts at Morningstar, and earns over 40% gross margins.



In June, InvestorPlace.com&rsquo;s Omor Ibne Ehsan called KLA a tech trailblazer that&rsquo;s <a href="https://investorplace.com/2024/06/7-stocks-to-buy-if-you-think-well-see-nasdaq-20k-in-2024/">paving the way in AI, 5G and Internet of Things</a>:




Although the firm&rsquo;s growth has moderated recently, I think the company&rsquo;s consistent ability to surpass Wall Street projections bodes well for its future prospects. As the semiconductor industry continues to boom, driven by insatiable demand for cutting-edge chips, KLAC is poised to thrive. If it maintains its momentum and the Nasdaq soars past 20,000, I wouldn&rsquo;t be surprised to see the stock catapult beyond the $1,000 mark.




The recent selloff now means Ehsan&rsquo;s $1,000 target price represents almost a 40% upside from current prices. The company scores a strong 88 with Prometheus, and analysts have raised their current-year earnings estimates by 5% over the past 30 days.



<h2>Microsoft (MSFT)</h2>



Joel Baglole writes this week that a <a href="https://investorplace.com/2024/08/take-advantage-of-the-tech-selloff-and-buy-microsoft-stock/">buying opportunity has finally opened up</a> with Microsoft (NASDAQ:<a href="https://investorplace.com/stock-quotes/msft-stock-quote/">MSFT</a>), a company that markets have sold off:




Microsoft delivered a Q2 print that was strong overall and exceeded Wall Street targets on the top and bottom lines. Most analysts raised their targets on Microsoft stock after the Q2 earnings were made public&hellip;



However, MSFT stock has been pulled lower since the beginning of July amid the broad pullback in technology securities. In the last month, Microsoft stock has declined 13%. This presents a golden opportunity to buy the dip in a best-in-class stock that has a track record of rewarding shareholders.




Essentially, Microsoft is beginning to catch up in enterprise-focused cloud computing &ndash; an area that Amazon.com (NASDAQ:<a href="https://investorplace.com/stock-quotes/amzn-stock-quote/">AMZN</a>) once dominated. Azure cloud service revenues rose 29% in the quarter, well ahead of Amazon&rsquo;s 19% growth rate. It&rsquo;s an increasingly lucrative segment that&rsquo;s helped increase Microsoft&rsquo;s quarterly revenues by $4.5 billion. InvestorPlace.com&rsquo;s Faisal Humayun additionally notes that Microsoft&rsquo;s Azure AI <a href="https://investorplace.com/2024/08/3-technology-stocks-to-buy-after-a-20-30-correction/">could bring in as much as $200 billion in five years</a>, making it a solid firm to buy the dip.



Prometheus awards Microsoft a strong score of 88.



<h2>Symbotic (SYM)</h2>



Last month, InvestorPlace.com writer Eddie Pan noted that warehouse automation firm Symbotic had fallen 25% on weak guidance. (Yes, the same one that previously rose 400%.) He explains <a href="https://investorplace.com/2024/07/symbotic-sym-stock-is-down-25-on-weak-guidance-whats-going-on-with-the-ai-darling/">what&rsquo;s going on with the AI darling</a>:




Guidance is where Symbotic struggled. The company guided for fourth-quarter revenue of between $455 million and $475 million and adjusted EBITDA between $28 million and $32 million. Analysts were expecting revenue of $516.84 million, meaning that the midpoint of Symbotic&rsquo;s revenue missed the target by a significant 10%.




A deeper read shows that revenue forecast cuts were a direct result of a planned in-sourcing initiative, which will decrease revenues in the near term and increase profits for the long run. Management realized that much of its outsourcing was costing the firm too much and has opted for slower, more profitable growth.



That&rsquo;s why Pan also notes that Wall Street analysts expect the Massachusetts-based firm to quickly recover.



The recent stock market selloff now provides a perfect opportunity to jump in on this high-potential stock. Prometheus award shares a score of 87.8, putting it in the top 2% of large-cap companies.



<h2>Intel (INTC)</h2>



Finally, our most contentious buy-the-dip pick this week is Intel (NASDAQ:<a href="https://investorplace.com/stock-quotes/intc-stock-quote/">INTC</a>), a firm I previously noted had lost almost 50% of its market value in a month.



The reasons for Intel&rsquo;s decline are obvious&hellip; at least in hindsight:



<ul><li>Innovation. In 2018, the company failed to deliver its 10-nanometer CPU, and has been catching up with subsequent standards ever since.</li>



<li>Competition. Arm architecture is now rivaling Intel&rsquo;s x86 platform in performance; some believe Intel could lose as much as 50% market share in CPUs from this.</li>



<li>Strategy. Intel has lagged GPU makers in developing AI-specific chips, leaving the sector wide open for players like Nvidia and Advanced Micro Devices (NASDAQ:<a href="https://investorplace.com/stock-quotes/amd-stock-quote/">AMD</a>).</li>
</ul>Perhaps worst of all, Intel&rsquo;s latest products appear to have been rushed. Many of its 13th and 14th generation CPUs are allegedly causing instabilities in both desktops and servers.



However, selloffs can sometimes go too far. As InvestorPlace.com&rsquo;s David Moadel wrote last week, <a href="https://investorplace.com/2024/08/intc-bloodbath-aftermath-buy-intel-stock-because-no-one-else-wants-to/">it&rsquo;s time to buy Intel&rsquo;s stock because no one else wants to</a>:




At this point, there&rsquo;s practically nothing left for Intel&rsquo;s shareholders to fear&hellip;



It&rsquo;s hard to envision the rainbow that&rsquo;s coming when it&rsquo;s storming. Intel is going through a rough period, but Intel CEO Pat Gelsinger assured that the aforementioned decisions (layoffs, dividend suspension) were &ldquo;painful and hard&rdquo; but necessary&hellip;



Unless you really think Intel&rsquo;s headed for Chapter 11, now&rsquo;s the time to exercise your contrarian muscles and buy a few shares.




Gelsinger is also putting his money where his mouth is. This week, the veteran executive bought 12,500 shares of his company&rsquo;s stock. And he might be onto something. Prometheus awards Intel a score of 85, suggesting that the selloff has finally gone too far.



On the date of publication, the responsible editor did not have (either directly or indirectly) any positions in the securities mentioned in this article.



Thomas Yeung is a market analyst and portfolio manager of the Omnia Portfolio, the highest-tier subscription at InvestorPlace. He is the former editor of Tom Yeung&rsquo;s Profit &amp; Protection, a free e-letter about investing to profit in good times and protecting gains during the bad.
<div>Thomas Yeung is a market analyst and portfolio manager of the Omnia Portfolio, the highest-tier subscription at InvestorPlace. He is the former editor of Tom Yeung&rsquo;s Profit &amp; Protection, a free e-letter about investing to profit in good times and protecting gains during the bad.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/2024/08/5-tech-stocks-to-buy-on-the-rebound/">5 Tech Stocks to Buy on the Rebound</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

5 Tech Stocks to Buy on the Rebound

THE LAWSUIT: A class action securities lawsuit was filed against Symbotic Inc. (SYM) that seeks to recover losses of Symbotic shareholders who were...

Symbotic Inc. Class Action: Levi & Korsinsky LLP Reminds Symbotic Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 14, 2024 – SYM

Industrial and financial stocks with the largest net increases in hedge fund popularity - GS

Craig-Hallum analyst Greg Palm assigned a Buy rating to the stock today. The company's shares closed yesterday at $22.27. Palm covers the Technolog...

Craig-Hallum Releases a Buy Rating on Symbotic (SYM)

AeroVironment soars to top industrial gainer of week, while Symbotic leads decliners

As the AI hype fuels the S&P 500 Index (SPX) surge, driven by AI-centric companies like Nvidia ($NVDA), the index has risen over 15% year-to-date. ...

Short Sellers Could be Targeting AI Stocks

In a report released today, Joseph C Giordano from TD Cowen maintained a Buy rating on Symbotic (SYM – Research Report), with a price target of $43...

Symbotic (SYM) Receives a Buy from TD Cowen

Symbotic Inc. falls after short report from Hunterbrook

Rocket Lab soars to top industrial gainer of week, Rentokil drops after profit warning

ATKR

AVAV

CMPR

CSWI

EWBC

HUBG

INTC

KLAC

LOAR

LUMN

NVDA

PCTY

POWL

PYCR

RKLB

RYAAY

Legal

Press Releases

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Symbotic Inc. (SYM)

SYMBOTIC INC. (NASDAQ: SYM) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Symbotic Inc. Investors of Upcoming Deadline

Shareholders that lost money on Symbotic Inc.(SYM) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More

Faruqi & Faruqi Reminds Symbotic Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 15, 2024 - SYM

DEADLINE ALERT for EXTR, PDD, CXM, and SYM: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Symbotic Inc. - SYM

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Symbotic, PDD Holdings, Extreme Networks, and Sprinklr and Encourages Investors to Contact the Firm

DEADLINE ALERT for PDD, CXM, SYM, STLA: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of October 15, 2024 in Symbotic Lawsuit – SYM

Lost Money on Symbotic Inc.(SYM)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

Symbotic

Symbotic (SYM) Forecast

Symbotic (NASDAQ:SYM) Stock, Quote.Headers.trade-ideas